Small molecule additive enhances cell uptake of 5-aminolevulinic acid and conversion to protoporphyrin IX
Administration of exogenous 5-aminolevulinic acid (5-ALA) to cancerous tissue leads to intracellular production of photoactive protoporphyrin IX, a biosynthetic process that enables photodynamic therapy and fluorescence-guided surgery of cancer. Cell uptake of 5-ALA is limited by its polar structure...
Saved in:
Published in | Photochemical & photobiological sciences Vol. 15; no. 11; pp. 148 - 1416 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Cham
Springer International Publishing
02.11.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Administration of exogenous 5-aminolevulinic acid (5-ALA) to cancerous tissue leads to intracellular production of photoactive protoporphyrin IX, a biosynthetic process that enables photodynamic therapy and fluorescence-guided surgery of cancer. Cell uptake of 5-ALA is limited by its polar structure and there is a need for non-toxic chemical additives that can enhance its cell permeation. Two zinc-bis(dipicolylamine) (ZnBDPA) compounds were evaluated for their ability to promote uptake of 5-ALA into Chinese Hamster Ovary (CHO-K1) cells and produce protoporphyrin IX. One of the ZnBDPA compounds was found to be quite effective, and a systematic comparison of cells incubated with 5-ALA (100 μM) for 6 hours showed that the presence of this ZnBDPA compound (10 μM) produced 3-fold more protoporphyrin IX than cells treated with 5-ALA alone. The results of mechanistic studies suggest that the ZnBDPA compound does not interact strongly with the 5-ALA. Rather, the additive is membrane active and transiently disrupts the cell membrane, permitting 5-ALA permeation. The membrane disruption is not severe enough to induce cell toxicity or allow passage of larger macromolecules like plasmid DNA.
Cells incubated with an admixture of 5-ALA (100 μM) and a zinc(
ii
)-bis(dipicolylamine) compound (10 μM) produced 3-fold more protoporphyrin IX than cells treated with 5-ALA alone. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1474-905X 1474-9092 1474-9092 |
DOI: | 10.1039/c6pp00151c |